Trust Size
$1M
Peak Price
$23.00
Current Price
$8.00
Return
-20.0%
What Happened
Semnur Pharmaceuticals, Inc. filed its S-1 registration in 2022 and completed its business combination in 2023. The company remains actively traded with 204 SEC filings on record.
Semnur Pharmaceuticals, Inc. entered the SPAC market in 2022 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2023.
SEC records show 204 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2022-04-05
S-1 Registration Filed
2023-12-15
Merger Proxy Filed (DEFM14A)
SEC Filing Details
CIK Number
1913577
Total SEC Filings
204
State of Incorporation
DE
Last Filing Date
2026-03-17
Business Location
New York, NY
Trust/Asset Size
$1M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for Semnur Pharmaceuticals